Amarpreet Sawhney

AMARPREET S. SAWHNEY is the Founder, President and Chief Executive
Officer of Confluent Surgical, Inc., a biosurgery company, based in
Waltham, Massachusetts. Confluent is developing in situ polymerized
biomaterials for prevention of post-surgical scarring and leakage from
tissues. Prior to Confluent, Dr. Sawhney was the technology Founder of
Focal, Inc. Focal was acquired by Genzyme Corporation in 2001. Dr.
Sawhney’s innovations are the subject of almost 100 issued and pending
patents in biomaterials and bio-surgery. Dr. Sawhney holds a PhD in
Chemical Engineering from the University of Texas at Austin and a
Bachelor’s degree in Chemical Engineering from the Indian Institute of
Technology, New Delhi.